Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcomes of Prostate Cancer Screening Using PSA, Biomarkers and MRI: The STHLM3MRI Trial

NCT07155759 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07155759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcomes of Prostate Cancer Screening Using PSA, Biomarkers and MRI: The STHLM3MRI Trial
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 1, 2024
Completion date
November 30, 2035
Enrollment
7,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer